Showing results (51-60 of 177) with videos related to

Sort By:
Pageof 18
Magnetic Resonance in Medicine|March 9, 2004
Measurement of brain glutamate using TE-averaged PRESS at 3TRalph Hurd, Napapon Sailasuta, Radhika Srinivasan, et al.
The New England Journal of Medicine|June 11, 2005
Progressive multifocal leukoencephalopathy in a patient treated with natalizumabAnnette Langer-Gould, Scott W Atlas, Ari J Green, et al.
Neuroimage|December 18, 2007
Whole brain voxel-wise analysis of single-subject serial DTI by permutation testingSungwon Chung, Daniel Pelletier, Michael Sdika, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 8, 2013
Constructing an adaptive care model for the management of disease-related symptoms throughout the course of multiple sclerosis--performance improvement CMEAaron E Miller, Bruce A Cohen, Stephen C Krieger, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 24, 2018
Efficacy and safety of teriflunomide in Asian patients with relapsing forms of multiple sclerosis: A subgroup analysis of the phase 3 TOWER studyAaron E Miller, Xianhao Xu, Richard Macdonell, et al.
Journal of Cutaneous Pathology|October 19, 2023
Assessment of specificity of dermatopathologic criteria for IgG4-related skin diseaseZachary Skopec, Mouaz Alsawas, Timothy Maxwell, et al.
Annals of Neurology|June 6, 2020
Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical EventChristine Lebrun-Frenay, Orhun Kantarci, Aksel Siva, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2004
The unique impact of changes in normal appearing brain tissue on cognitive dysfunction in secondary progressive multiple sclerosis patientsDarcy Cox, Daniel Pelletier, Claude Genain, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|April 25, 2020
Contribution of normal aging to brain atrophy in MSChristina J Azevedo, Steven Y Cen, Amir Jaberzadeh, et al.
Pageof 18